Display options
Cite
Schiereck T, Yeldan S, Kranz J, et al. Mikrobiomanalyse der Harnblase und probiotische Therapieoptionen bei Frauen mit rezidivierenden Harnwegsinfektionen. [Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]. Urologe A. 2021;61(1):41-51doi: 10.1007/s00120-021-01621-6.
Schiereck, T., Yeldan, S., Kranz, J., Schneidewind, L., Wagenlehner, F., Wieters, I., Vehreschild, M. J. G. T., Otto, T., & Barski, D. (2022). Mikrobiomanalyse der Harnblase und probiotische Therapieoptionen bei Frauen mit rezidivierenden Harnwegsinfektionen. [Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]. Der Urologe. Ausg. A, 61(1), 41-51. https://doi.org/10.1007/s00120-021-01621-6
Schiereck, T, et al. "Mikrobiomanalyse der Harnblase und probiotische Therapieoptionen bei Frauen mit rezidivierenden Harnwegsinfektionen." [Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]. Der Urologe. Ausg. A vol. 61,1 (2022): 41-51. doi: https://doi.org/10.1007/s00120-021-01621-6
Schiereck T, Yeldan S, Kranz J, Schneidewind L, Wagenlehner F, Wieters I, Vehreschild MJGT, Otto T, Barski D. Mikrobiomanalyse der Harnblase und probiotische Therapieoptionen bei Frauen mit rezidivierenden Harnwegsinfektionen. [Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections]. Urologe A. 2022 Jan;61(1):41-51. doi: 10.1007/s00120-021-01621-6. Epub 2021 Aug 23. German. PMID: 34424357; PMCID: PMC8381347.
Copy Download .nbib Format: NLM
Share it on

Urologe A. 2022 Jan;61(1):41-51. doi: 10.1007/s00120-021-01621-6. Epub 2021 Aug 23.

[Urinary bladder microbiome analysis and probiotic treatment options for women with recurrent urinary tract infections].

Der Urologe. Ausg. A

[Article in German]
T Schiereck, S Yeldan, J Kranz, L Schneidewind, F Wagenlehner, I Wieters, M J G T Vehreschild, T Otto, D Barski

Affiliations

  1. Urologische Klinik, Lukaskrankenhaus Neuss, Rheinland Klinikum, Preussenstr. 84, 41464, Neuss, Deutschland. [email protected].
  2. Urologische Klinik, Lukaskrankenhaus Neuss, Rheinland Klinikum, Preussenstr. 84, 41464, Neuss, Deutschland.
  3. Klinik für Urologie und Kinderurologie, St.-Antonius-Hospital Eschweiler, Akademisches Lehrkrankenhaus der RWTH Aachen, Eschweiler, Deutschland.
  4. Universitätsklinik und Poliklinik für Urologie, Universitätsklinikum Halle (Saale), Halle (Saale), Deutschland.
  5. Urologische Klinik und Poliklinik, Universitätsmedizin Rostock, Ernst-Heydemann-Str. 6, 18055, Rostock, Deutschland.
  6. Klinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Gießen, Gießen, Deutschland.
  7. Zentrum für Innere Medizin, Infektiologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Frankfurt am Main, Deutschland.
  8. Universität Duisburg-Essen, Essen, Deutschland.

PMID: 34424357 PMCID: PMC8381347 DOI: 10.1007/s00120-021-01621-6

Abstract

Novel preventive measures and therapeutic approaches are needed to reduce the frequency of recurrent urinary tract infections (rUTI) and the associated emergence of multidrug-resistant uropathogens. The aim of this review is to systematically present the available evidence on the urinary bladder microbiome of healthy women and those with rUTIs. In addition, relevant studies on the efficacy of probiotics in rUTIs are presented in a structured manner. This will provide an overview on the current state of research and an outlook on treatment strategies beyond the usual antimicrobial options.

© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Keywords: 16S-rRNA-sequencing; Fecal microbiota transplantation; Female bladder; Lactobacillus; Multidrug-resistant pathogens

References

  1. Aira A, Rubio E, Vergara Gómez A et al (2020) rUTI resolution after FMT for Clostridioides difficile infection. Infect Dis Ther 10:1065–1071 - PubMed
  2. Amabebe E, Anumba DOC (2020) Female gut and genital tract microbiota-induced crosstalk and differential effects of short-chain fatty acids on immune sequelae. Front Immunol 11:2184 - PubMed
  3. AWMF S3 Leitlinien Harnwegsinfektionen (2017) Leitlinienprogramm DGU: Interdisziplinäre S3 Leitlinie: Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Langversion 1.1–2. https://www.awmf.org/uploads/tx_szleitlinien/043-044l_S3_Harnwegsinfektionen_2017-05.pdf . Zugegriffen: 30. Mai 2021 (AWMF Registernummer: 043/044) - PubMed
  4. Bajic P, Wolfe AJ, Gupta GN (2019) The urinary microbiome. Urology 126:10–15 - PubMed
  5. BfArM (2020) Maßnahmen zur Minimierung des Risikos einer möglichen Übertragung von SARS-CoV‑2 durch Fäkale Mikrobiota-Transplantation (FMT). https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2020/RI-FMT.html . Zugegriffen: 12. Apr. 2021 - PubMed
  6. Biehl LM, Cruz Aguilar R, Farowski F et al (2018) Fecal microbiota transplantation in a kidney transplant recipient with recurrent urinary tract infection. Infection 46(6):871–874 - PubMed
  7. Bier N, Hanson B, Jiang Z‑D et al (2020) 1694. Successful gut decolonization of extended-spectrum β‑lactamase producing Klebsiella pneumoniae using oral lyophilized fecal microbiota transplant (FMT) in a woman with recurrent urinary tract infections. Open Forum Infect Dis 7(Supplement_1):S830–S831 - PubMed
  8. Bonkat G, Bartoletti R, Bruyère F et al (2020) Guidelines on urological infections. EAU, Arnhem - PubMed
  9. Brubaker L, Wolfe AJ (2015) The new world of the urinary microbiota in women. Am J Obstet Gynecol 213(5):644–649 - PubMed
  10. Bschleipfer T (2019) Mikrobiom, Harnwegsinfekt und OAB – wie hängt das zusammen? UroForum 10(11):27–28 - PubMed
  11. Caskurlu H, Culpan M, Erol B et al (2020) Changes in antimicrobial resistance of urinary tract infections in adult patients over a 5-year period. Urol Int 104(3-4):287–292 - PubMed
  12. Chanishvili N (2016) Bacteriophages as therapeutic and prophylactic means. Curr Drug Deliv 13(3):309–323 - PubMed
  13. Chen C, Hao L, Wei W et al (2020) The female urinary microbiota in relation to the reproductive tract microbiota. Gigabyte. https://doi.org/10.46471/gigabyte.9 - PubMed
  14. Chen Z, Phan M‑D, Bates LJ et al (2018) The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection. Int Urogynecol J 29(12):1775–1782 - PubMed
  15. Gaitonde S, Malik RD, Zimmern PE (2019) Financial burden of recurrent urinary tract infections in women. Urology 128:47–54 - PubMed
  16. Gottschick C, Deng Z‑L, Vital M et al (2017) The urinary microbiota of men and women and its changes in women during bacterial vaginosis and antibiotic treatment. Microbiome 5(1):99 - PubMed
  17. Grosen AK, Povlsen JV, Lemming LE et al (2019) Faecal microbiota transplantation eradicated extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from a renal transplant recipient with recurrent urinary tract infections. Case Rep Nephrol Dial 9(2):102–107 - PubMed
  18. Hilt EE, McKinley K, Pearce MM et al (2014) Urine is not sterile. J Clin Microbiol 52(3):871–876 - PubMed
  19. Hocquart M, Pham T, Kuete E et al (2019) Successful fecal microbiota transplantation in a patient suffering from irritable bowel syndrome and recurrent urinary tract infections. Open Forum Infect Dis 6(10):ofz398 - PubMed
  20. Karstens L, Asquith M, Davin S et al (2016) Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol 6:78 - PubMed
  21. Keen EC, Tasoff P, Hink T et al (2020) Microbiome restoration by RBX2660 does not preclude recurrence of multidrug-resistant urinary tract infection following subsequent antibiotic exposure. Open Forum Infect Dis 7(3):ofaa42 - PubMed
  22. Komesu YM, Richter HE, Carper B et al (2018) The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int Urogynecol J 29(12):1785–1795 - PubMed
  23. Kontiokari T, Sundqvist K, Nuutinen M et al (2001) Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 322(7302):1571 - PubMed
  24. Koradia P, Kapadia S, Trivedi Y et al (2019) Probiotic and cranberry supplementation for preventing recurrent uncomplicated urinary tract infections in premenopausal women. Expert Rev Anti Infect Ther 17(9):733–740 - PubMed
  25. Kutter E, de Vos D, Gvasalia G et al (2010) Phage therapy in clinical practice. Curr Pharm Biotechnol 11(1):69–86 - PubMed
  26. Leitner L, Ujmajuridze A, Chanishvili N et al (2021) Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate. Lancet Infect Dis 21(3):427–436 - PubMed
  27. Lewis DA, Brown R, Williams J et al (2013) The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol 3:41 - PubMed
  28. Magistro G, Marcon J, Eismann L et al (2020) Die Rolle des Mikrobioms in der Urologie. Urologe 59(12):1463–1471 - PubMed
  29. McDonald M, Kameh D, Johnson ME et al (2017) A head-to-head comparative phase II study of standard urine culture and sensitivity versus DNA next-generation sequencing testing for urinary tract infections. Rev Urol 19(4):213–220 - PubMed
  30. Meštrović T, Matijašić M, Perić M et al (2020) The role of gut, vaginal, and urinary microbiome in urinary tract infections. Diagnostics (Basel) 11(1):7 - PubMed
  31. Pearce MM, Hilt EE, Rosenfeld AB et al (2014) The female urinary microbiome. mBio 5(4):e01283-14 - PubMed
  32. Price TK, Dune T, Hilt EE et al (2016) The clinical urine culture. J Clin Microbiol 54(5):1216–1222 - PubMed
  33. Price TK, Wolff B, Halverson T et al (2020) Temporal dynamics of the adult female lower urinary tract microbiota. mBio 11(2):e00475-20 - PubMed
  34. Price TK, Hilt EE, Thomas-White K et al (2020) The urobiome of continent adult women. BJOG 127(2):193–201 - PubMed
  35. Reid G, Bruce AW, Taylor M (1992) Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 14(1):11–16 - PubMed
  36. Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR‑1 and L. fermentum RC-14 significantly alters vaginal flora. FEMS Microbiol Immunol 35(2):131–134 - PubMed
  37. Reid G, Bruce AW (2006) Probiotics to prevent urinary tract infections. World J Urol 24(1):28–32 - PubMed
  38. Schwenger EM, Tejani AM, Loewen PS (2015) Probiotics for preventing urinary tract infections in adults and children. Cochrane Database Syst Rev 12:CD8772 - PubMed
  39. Siddiqui H, Nederbragt AJ, Lagesen K et al (2011) Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons. BMC Microbiol 11:244 - PubMed
  40. Siddiqui H, Lagesen K, Nederbragt AJ et al (2012) Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 12:205 - PubMed
  41. Stalenhoef JE, Terveer EM, Knetsch CW et al (2017) Fecal microbiota transfer for multidrug-resistant gram-negatives. Open Forum Infect Dis 4(2):ofx47 - PubMed
  42. Stallmach A, Steube A, Grunert P et al (2020) Fecal microbiota transfer. Dtsch Arztebl Int 117(3):31–38 - PubMed
  43. Tariq R, Pardi DS, Tosh PK et al (2017) Fecal microbiota transplantation for recurrent Clostridium difficile infection reduces recurrent urinary tract infection frequency. Clin Infect Dis 65(10):1745–1747 - PubMed
  44. Thapaliya J, Khadka P, Thapa S et al (2020) Enhanced quantitative urine culture technique, a slight modification, in detecting under-diagnosed pediatric urinary tract infection. BMC Res Notes 13(1):5 - PubMed
  45. Thomas-White KJ, Hilt EE, Fok C et al (2016) Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J 27(5):723–733 - PubMed
  46. Thomas-White KJ, Gao X, Lin H et al (2018) Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. Int Urogynecol J 29(12):1797–1805 - PubMed
  47. Umek W (2019) Das urogenitale Mikrobiom und seine Bedeutung für den weiblichen Harntrakt. J Urol Urogynäkol AT 26(1):20–22 - PubMed
  48. Vahlensieck W, Bauer HW, Piechota H et al (2015) Rezidivierende Harnwegsinfektionen. Dtsch Arztebl 112(37):16 - PubMed
  49. Wang T, Kraft CS, Woodworth MH et al (2018) Fecal microbiota transplant for refractory Clostridium difficile infection interrupts 25-year history of recurrent urinary tract infections. Open Forum Infect Dis 5(2):ofy16 - PubMed
  50. Wolfe AJ, Toh E, Shibata N et al (2012) Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol 50(4):1376–1383 - PubMed
  51. Wolff BJ, Price TK, Joyce CJ et al (2019) Oral probiotics and the female urinary microbiome. Int Urol Nephrol 51(12):2149–2159 - PubMed

Publication Types